MHRA Papers - Part 22
More navel gazing and delays - enough!
SUMMARY: The Secret Squirrels appear to have missed a possible harm signal for the Oxford AstraZeneca COVID-19 vaccine
After the great interest shown by the UK Parliament, our readers, and the MHRA's enablers, we continue reviewing the minutes of the 31 March, 6, 12 and 19 April 2021 meetings of the MHRA’s Commission On Human Medicines (CHM) COVID-19 Vaccines Benefit Risk Expert Working Group. Oops…. the Minutes have been withdrawn in the interests of transparency, silly us. Never mind; here is the PDF.
We have lumped together these meetings as the secret squirrels discussed possible thromboembolic and autoimmune harms and came to the usual conclusion of a favourable benefit-risk ratio. So, business as usual. This is despite, for example, repeated reports of the very rare Cerebral venous sinus thrombosis (CVST) in people with no known risk factors for thrombophilia. This despite not finding any death signals in the Yellow Card reporting system which everyone who knows of its existence…
Keep reading with a 7-day free trial
Subscribe to Trust the Evidence to keep reading this post and get 7 days of free access to the full post archives.